9999999997-11-014720.txt : 20110830
9999999997-11-014720.hdr.sgml : 20110830
20110830115828
ACCESSION NUMBER: 9999999997-11-014720
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20110830
DATE AS OF CHANGE: 20110830
20110830
20110830
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: OPTIMER PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001142576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330830300
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33291
FILM NUMBER: 111064820
BUSINESS ADDRESS:
STREET 1: 10110 SORRENTO VALLEY ROAD
STREET 2: SUITE C
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8589090736
MAIL ADDRESS:
STREET 1: 10110 SORRENTO VALLEY ROAD
STREET 2: SUITE C
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S
M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR
M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T
M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.,(D$&(&8A8&C`5F,
M&8H9&!H9N!G8?[G#5(HLA^IH`^MB4)&$\!FY``(,`)9#!",-"F5N9'-T7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@
M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)=
M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S
M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH-
M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9II%+;;AHQ$/V5>6P?J"][\2)%2)"$
MM%*A*+MJ*B$>7'!AI;V@746U/>>,Y\SZB!@X"`5J""(!
M$>`RA$!)D!Q4$H(4(+@0<'7%;@_V+K7:&MS?I8*R.-R/1FQ:5Q9C628I&6.X
M=9D>7C3U.C5VR18W4Y:9@UV-1DC_MH!?NF@-;F8@6#H^'M,9\$]=V4NG"A!R])H:(O5A?Y>EQM"P.JVX1B>Z-<1YJ?QMM:XW>;5E#WDUKMK\?)[F36NO=[J!0%Y4H8>F1_JJ
MCPPA%$L??UH2E#6/QBD[R\.K-W;7+F7$@4;$_=H?A`5!`)Y#C.?FY:D_E)3'
M+\TX5A"CZY1*W`R2H6-1?!B&GH=QXOBL*(H=ZN_AY_4TNOH<0KSA]'5J,%>J
MQ'>":X*=4.R$>2YI"#RR>J\)X[]-R-7;3/BJ_\(7_)?(]]GOK[TTGWG.;\=W4.>\J_.SS4Z)B&G#,^Z=%HWR#54M[\Z!QWU
M]#U';K[4Z[I$U\D>YC3X/;KPCP`#`-8:AZ$-"F5N9'-T1EX\(S_2::^7@<$G.3?`1N#RRCCD,SL3O*K7;@!C>/S4Y=Z
M'HN5N5V\#A[)PVJ9S!TWI#&9P<9Q.8U(XE!&)HG9G=M-H6\:T6&ACS:1AB13IKWUISWU@O9W.TF/P.R7H^2>[PQO*%
MAB/>0V:-#?4J8O)M#AUA2-7<$@23:0+W"V!QH/CW26@=8BW"3S)EC(;L(EZ@
MSNCJ;V190%OLT-FZQ73]<.OZABWL/(6%=U@\RWB;F3Q#%E9[.5.
M%(U,0;EOBN)<7LJ"U@*%BO-EDF5EM<.6R#6!7$W^D[JOM/(V/&O[
MJHY6[($1^[[,\_)5]9J%RM^]5'KJ%%U;O,H\!P5W*U"$N=""1.C*G4:'+]+H
MC.ZB*QZ)25&WKC)1:HUPI`BE24;@*"I9[FJHCR)3FMI][:!IOS^=KE::>GSC
M"`SCR#8.=!T-CNX@YE&<0"P.N:*@*MOG@WUB6]0>&]H%MFNHEWC>41MVVIN9
M&EJM?12&?QQF)C)A5+EU3)N:_:`?7P#7:N*&8%^I/DAZK6JV[30VC4_+K273^?B#D7SG.J71=L
M=)?2U+I6=[&:,-WDNPIW-.Y$YR?K%M>1\V['0I@:"!9P:T):W*?(HF_-?6UM
ML6B>#"'S9/"_``,`H&+#[0T*96YDG)E4WI.
M5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O
M(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`T+C(N,2UC,#0S(#4R+C,W,C&UL;G,Z6YT87@M;G,C(CX*("`@("`@/')D9CI$97-C&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M
M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI0&UP.D-R96%T941A
M=&4^,C`Q,2TP."TS,%0Q,3HU-CHP."TP-#HP,#PO>&UP.D-R96%T941A=&4^
M"B`@("`@(#PO&UP34TZ26YS=&%N8V5)1#YU=6ED.F,S,#`T.#&UP34TZ26YS=&%N8V5)1#X*
M("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ'5!:DZ@?(RQ"L(P%$5_Y6U-AB9I;+2*"&('EX*@Z.)2FXB!
MT">OK_C[9G!VN9SAG+L&`]NMWL_\0A+'>>1`9ZD/%'J..+8]!]%NK*DJTRSR
MNJ5I2E,7QA0_*V>G\T#QS4[YE.`::,HE.&65E;I#___D1.CG(9#8#X2/GJ&-
M$\>4`L%:UQ.H%$5Q`B:?7@"P&!D8@
MP?0?2#`R``08`':`!1L-"F5N9'-T